Owens & Minor Q1 adj EPS $0.23, revenue $2.63B; reaffirms FY guide, active on P&HS sale

ACCENDRA HEALTH INC/VA/

2025-Q1 EPS reported -$0.32 revenue$2,632,048,000

Adjusted EPS $0.23 vs $0.19 YoY; GAAP net loss $(0.32) per share vs $(0.29).
Revenue $2.63B (+0.7% YoY); Patient Direct segment margin +173 bps.
Adjusted EBITDA $121.9M vs $116.3M YoY; full-year 2025 guidance reaffirmed.
Company actively engaged in potential sale of Products & Healthcare Services segment.
Integrating planned Rotech acquisition; monitoring tariff policy impacts.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.